VRNO insider trading
OTC Markets OTCQX HealthcareVerano Holdings Corp. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Verano Holdings Corp.
Verano Holdings Corp. operates as a vertically integrated multi-state cannabis operator in the United States. The company engages in the cultivation, processing, wholesale, and retail distribution of cannabis in Arizona, Connecticut, Florida, Illinois, Maryland, Massachusetts, Michigan, Nevada, New Jersey, Ohio, Virginia and West Virginia, and Pennsylvania. It offers cannabis products under the Encore, Avexia, MUV, Savvy, BITS, Verano, and Essence brands for medical and adult-use markets. The company is headquartered in Chicago, Illinois.
Company website: www.verano.com
VRNO insider activity at a glance
FilingIQ has scored 68 insider transactions for VRNO since Dec 1, 2025. The most recent filing in our index is dated Apr 20, 2026.
Across the full history, 0 open-market purchases
and 4 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for VRNO?
- FilingIQ tracks 68 Form 4 insider transactions for VRNO (Verano Holdings Corp.), covering filings from Dec 1, 2025 onwards. 13 of those were filed in the last 90 days.
- Are VRNO insiders net buyers or net sellers?
- Across the full Form 4 history for VRNO, 0 transactions (0%) were open-market purchases and 4 (6%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does VRNO insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is VRNO in?
- Verano Holdings Corp. (VRNO) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $405.23M.
Methodology & sources
Every VRNO insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.